Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered

Documenti analoghi

• A novel FUS::BEND2 fusion expanding the molecular spectrum of astroblastomas
  di: Arnault Tauziède-Espariat, et al.
  Pubblicazione: (2024-12-01)
• Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered
  di: Arnault Tauziède-Espariat, et al.
  Pubblicazione: (2024-06-01)
• A malignant choroid plexus tumor with heterologous differentiation and BAP1 deletion suggesting choroid plexus blastoma
  di: Arnault Tauziede-Espariat, et al.
  Pubblicazione: (2025-10-01)
• Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome
  di: Arnault Tauziède-Espariat, et al.
  Pubblicazione: (2025-01-01)
• Assessment of the Relationship Between Facial and Dental Midlines with Anatomical Landmarks of the Face and Oral Cavity
  di: Abolfazl Farahani, et al.
  Pubblicazione: (2019-12-01)